R. Roesler

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study

T. Friede, U. Ziemann, M. Krumbholz, 2020, Contemporary clinical trials communications.

Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German–Austrian retrospective multicenter study in patients with a clinically isolated syndrome

F. Paul, M. Buttmann, A. Winkelmann, 2016, Journal of Neurology.

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

S. Rauch, C. Enzinger, X. Montalban, 2015, Multiple sclerosis.

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

À. Rovira, C. Enzinger, X. Montalban, 2015, Brain : a journal of neurology.

Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing–remitting multiple sclerosis

M. Hecker, U. Zettl, H. Tumani, 2016, Multiple sclerosis.